Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

NHS needle approval

29th Jan 2008 10:41

International Medical Devices PLC29 January 2008 INTERNATIONAL MEDICAL DEVICES WIN APPROVAL FOR ITS RETRACTABLE NEEDLE FROM THE NATIONAL HEALTH SERVICE International Medical Devices plc, (IMD), the AIM listed healthcare company, haswon an endorsement to sell its Retractable Needle across the National HealthService. From April, the NHS will market the needle to all 280 NHS Trusts(including Scotland) through its approved product list. The retractable needlewill reduce the number of accidents that occur in the health service where staffaccidentally "stick" themselves when they are carrying out life saving tasks. Currently, each of the 280 NHS Trusts are paying out an average of £600,000 perannum to staff who have harmed themselves as a result of accidental needleinjuries including eight nurses who have tragically contracted HIV. IMD's retractable needles are manufactured in China to a world class qualitystandard, and operate by releasing the needle when it needs to be used and canthen be retracted into a protective housing when finished. To avoid infection,the needle can only be used once and the housing has an automatic, tamper-prooflocking device to avoid reuse. IMD has appointed InterVene Ltd to market the Retractable Needle across the NHSTrusts. InterVene was founded by Matthew Root, who is the former CommercialDirector of IMD who decided to form the Company because of the massive benefitsthe needle can provide in terms of staff safety and reducing the huge sums thatare paid out in compensation. It is expected that the first orders for theneedle will start in the second quarter of 2008. Bill McGrath, Chief Executive of International Medical Devices, commented: "Weare delighted that the NHS has agreed to endorse our needles. Safety and theeradication of injury and infection in hospitals is paramount and this productwill help to achieve both. It is a very simple device to operate and is pricecompetitive. We took the decision to appoint InterVene to market the needle forus because Matthew has a unique understanding of the product." Matthew Root, Chief Executive of InterVene Ltd, commented: "I am delighted to beinvolved with the marketing of IMD's retractable needle. Needlestick injuriesare the silent threat that haunt healthcare systems all over the world. Surety(TM) Needle is a unique product which has benefits for both the NHS andthe veterinary market where the same, sometimes fatal, accidents occur.InterVene has been established with the specific intention of distributingsafety medical products to the healthcare industry here in the UK and to exportmarkets around the world." For further information, contact: International Medical Devices Plc:Bill McGrath 020 3008 4732 J M Finn Capital Markets:Geoff Nash 020 7600 1658 Ends This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,395.48
Change-57.20